Breadcrumb

Breadcrumbs

Press Releases

Press Releases

News, Events, Updates, Breakthroughs

Journalists may direct questions to mediainquiries@dsi.com. Or click here for direct contact information for Daiichi Sankyo U.S. Public Affairs team

Press announcements are archived by release date, searchable by topic:

From To
Date Title
Thu Jan 18 00:00:00 GMT-04:00 2018
Daiichi Sankyo Presents Updated Data for DS-8201 in Patients with HER2-Expressing Gastric Cancer at ...
PDF (271 KB)
Thu May 31 00:00:00 GMT-04:00 2018
Daiichi Sankyo Initiates Phase 2 Study of DS-8201 in Patients with Advanced HER2-Overexpressing or ...
PDF (189 KB)
Mon May 14 00:00:00 GMT-04:00 2018
Zymeworks and Daiichi Sankyo Expand Immuno-Oncology Collaboration Focused on Bispecific Antibodies
PDF (171 KB)
Fri Jun 30 00:00:00 GMT-04:00 2017
Daiichi Sankyo Announces Top-line Results from Phase 3 Global Clinical Development Program Evaluati ...
PDF (96 KB)
Tue Jul 11 00:00:00 GMT-04:00 2017
Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center Announce Cancer Research Collaborat ...
PDF (174 KB)
Mon Aug 21 00:00:00 GMT-04:00 2017
Daiichi Sankyo, Inc. Announces Its Clinical Presentations at ESC Congress 2017
PDF (235 KB)
Thu Aug 31 00:00:00 GMT-04:00 2017
Daiichi Sankyo Showcases New Insights on Multiple Oncology Compounds at the European Society for Me ...
PDF (230 KB)
Thu Aug 31 00:00:00 GMT-04:00 2017
Daiichi Sankyo Announces Positive Top-line Results from Phase 3 Clinical Trial Evaluating Mirogabal ...
PDF (98 KB)
Thu Sep 14 00:00:00 GMT-04:00 2017
MD Anderson and Daiichi Sankyo Enter Research Collaboration to Accelerate Development of Acute Myel ...
PDF (260 KB)
Tue Dec 12 00:00:00 GMT-04:00 2017
Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in H ...
PDF (215 KB)
Showing 1 - 10 of 47 results.

Press Release More Stories

More Stories

Who We Are

As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, Inc. draws on a rich heritage of innovation, integrity and accountability..

read more ...